Search Within
Document Type
278-169-7
Applied Filters:
Keyword:'278-169-7'
Showing 1-30 of 39 results for "278-169-7" within Technical Documents
Anisomycin from Streptomyces griseolus (A9789)
Commun., 278, 550-6 (2000)
5. Curtin. J.F. and Cotter T.G., Br. J. Cancer, 87,
1188-94 (2002).
6. Torocsik, B. and Szeberenyi. J., Eur. J. Neurosci.,
12, 527-32 (2000).
Data Sheet - G6916
, and Lane M.D., Proc. Natl. Acad. Sci.
USA , 97, 12446-12450 (2000).
7. O’Reilly, M.A., et al., Am. J. Physiol., 278,
L552-L559 (2000).
8. Cui, K., et al., J. Biol. Chem., 275
Data Sheet - P0050
Manevich, Y., and Fisher, A.B., Free Radic. Biol.
Med., 38, 1422-1432 (2005).
7. Kumin, A. et al., Am. J. Pathol., 169, 1194-1205
(2006).
8. Power, J.H.T. et al., Acta Neuropathol., 115, 611-
Data Sheet - P0058
Manevich, Y., and Fisher, A.B., Free Radic. Biol.
Med., 38, 1422-1432 (2005).
7. Kumin, A. et al., Am. J. Pathol., 169, 1194-1205
(2006).
8. Power, J.H.T. et al., Acta Neuropathol., 115, 611-
Product Information Sheet - P0453
phosphotyrosyl phosphatase inhibitors leads to
activation of cyclooxygenase-2 gene. J. Biol.
Chem., 278(9), 6992-7000 (2003).
6. Cambien, B., et al., Src-regulated extracellular
signal-related kinase
Data Sheet - M6569
, M., et al., Gene, 301, 43-51 (2002).
7. Razin, A., and Cedar, H., Cell, 77, 473-476
(1994).
8. Riggs, A.D., and Pfeifer, G.P., Trends Genet.,
8, 169-174 (1992).
9. Sakai, T., et al., Am.
Data Sheet - T2200
1799 (1990).
5. MacRae, T.H., Eur. J. Biochem., 244, 265-278
(1997).
6. Roach, M.C., et al., Cell Motil. Cytoskel., 39,
273-285 (1998).
7. Luduena, R.F., Int. Rev. Cytol., 178, 207-275
(1998
A blocker of store-operated calcium (SOC) entry (MRS1845)
(1999).
2. Barritt, G.J., Biochem. J., 337, 153-169 (1999).
3. Nilius, B., et al., Endothelium, 10, 5-15 (2003).
4. Liu, X., et al., J. Biol. Chem., 278, 11337-11343 (2003).
5. Harper, J.L., et al., Biochem
MRS 1845- A blocker of store-operated calcium (SOC) entry that does not activate intracellular calcium release
(1999).
2. Barritt, G.J., Biochem. J., 337, 153-169 (1999).
3. Nilius, B., et al., Endothelium, 10, 5-15 (2003).
4. Liu, X., et al., J. Biol. Chem., 278, 11337-11343 (2003).
5. Harper, J.L., et al., Biochem
HEPES Sodium Salt Specification Comparison
C8H17N2O4SNa MDL Number MFCD00036463 Useful pH range 6.8 - 8.2
Molecular Weight 260.29 EG/EC Number 278-169-7 pKa (at 25) 7.5
CAS Number 75277-39-3
Sigma-Aldrich HEPES Sodium Salt Specifications Comparison
Data Sheet - D4943
et al., Biochim. Biophys. Acta,
657(1), 179-189 (1981).
3
7. Kenny, A.J., et al., Biochem. J., 157(1), 169-182
(1976).
8. Hegan, M., et al., Adv. Exp. Med. Biol.
XP725 Antibody Number-Lot Number 071M4826
1.6 21 22 23 24 45 46 47 48 69 70 71 72 93 94 95 96
2.1 97 98 99 100 121 122 123 124 145 146 147 148 169 170 171 172
2.2 101 102 103 104 125 126 127
Quality Control Range Sheet- A6602-106 and A6602-206
mL
Control 2 2322 – 4822 pg/mL Control 2 177 – 367 pg/mL
IP-10 Control 1 81 – 169 pg/mL TNF α Control
MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors
85 45 207 5751
std
6
180 97 200 138 278 392 75 286 154 276 184 306 64 352 8683
193 92 206 147 283 407 80 300 155 291 211 316 73 374 8251
Celltransmissions Newsletter
1825 (2000).
7. Huai, Q., et al., J. Biol. Chem., in press (2004).
8. Sung, B.J., et al., Nature, 425, 98-102 (2003).
9. Patel, S.B., et al., Acta Crystallogr. D. Biol. Crystallogr., 60, 169-171 (2004).
Protein Tyrosine Phosphatases- Potential Roles in Disease
et al., J. Antibiot., 48, 1460-1466 (1995).
101. Lajas, A.I., et al., Mol. Cell. Biochem., 205, 162-169 (2000).
102. Li, S. and Whorton, A.R., Arch. Biochem. Biophys., 410, 269-279 (2003).
103 Pathak, M.
The Ubiquitin-Proteasome System- Death of Proteins is Required for Life of Cells
(2001).
5. Weissman, A.M., Nature Rev. Cell Mol. Biol., 2, 169-179 (2001).
6. Joazeiro, C.A.P. and Weissman, A.M., Cell, 102, 549-552 (2000).
7. Deshaies, R.J., Annu. Rev. Cell Dev. Biol., 15, 435-467 (
Biologics 31.1
Sansal, I., and Sellers, W.R. 2004. J. Clin. Oncol. 22, 2954. Birle, D., et al. 2002.
J. Immunol. 169, 286. Torres, J., and Pulido, R. 2001. J. Biol. Chem. 276, 993.
Looking for Reliable Akt Assay Kits
User Guide- 1.73027 - EN
storage in ambient relative humidity conditions of 20% to 95%
Non-condensing
Dimensions 418 × 278 × 169 mm (width × depth × height)
Weight approx. 6.8 kg
Warranty 24 months
EMC Directive 2014
User Guide- 1.73026 - EN
storage in ambient relative humidity conditions of 20% to 95%
Non-condensing
Dimensions 418 × 278 × 169 mm (width × depth × height)
Weight approx. 6.8 kg
Warranty 24 months
EMC Directive 2014
User Guide- 1.73028 - EN
storage in ambient relative humidity conditions of 20% to 95%
Non-condensing
Dimensions 418 × 278 × 169 mm (width × depth × height)
Weight approx. 6.8 kg
Warranty 24 months
EMC Directive 2014
Inhibitor Sourcebook 3rd Edition
Tokyo) 129, 193.
Rokolya, A., and Singer, H.A. 2000. Am. J. Physiol. 278, C537.
Fukunaga, K., and Miyamoto, E. 1999. Jap. J. Pharmacol. 79, 7.
Kemp, B.E., et al. 1994. In Protein Kinases (Woodgett, J.R., ed
XP725 Antibody List Lot 089K4791
NA M
120 Anti Cy3+Cy5 C0992 NA NA M
144 Anti Cy3+Cy5 C0992 NA NA M
168 Anti Cy3+Cy5 C0992 NA NA M
169 Ciliated Cell Marker C5867 NA NA M y n/d n/d
192 Anti Cy3+Cy5 C0992 NA NA M
212 Pan Cytokeratin C2931
XP725 Antibody List Lot 129K4831
d n/d
67 Bcl-x B9304 598 BCL2L1 P NP_001182.1 y y y
68 Bcl-xL B9429 598 BCL2L1 M NP_001182.1 y y y
278 Filensin F1043 631 BFSP1 M NP_001155177.1,NP_001186.1 y n/d n/d
69 BID B4305 637 BID P NP_001187.1
XP725 Antibody List Lot 129K4830
d n/d
67 Bcl-x B9304 598 BCL2L1 P NP_001182.1 y y y
68 Bcl-xL B9429 598 BCL2L1 M NP_001182.1 y y y
278 Filensin F1043 631 BFSP1 M NP_001155177.1,NP_001186.1 y n/d n/d
69 BID B4305 637 BID P NP_001187.1
Bioreactor Systems for Bone Tissue Engineering
techniques
and three-dimensional matrices for mesenchymal cell at-
tachment. J Tissue Eng Regen Med 5, 169, 2011.
46. Timmins, N.E., et al. Three-dimensional cell culture and
tissue engineering in a T-CUP
XP725 Worksheet for Lot Number 071M4826
2 2 4 7 aCatenin C2081
272 2 2 4 8 aCatenin C2081
273 2 2 5 1 bCatenin C7207
274 2 2 5 2 bCatenin C7207
275 2 2 5 3 bCatenin C7082
276 2 2 5 4 bCatenin C7082
277 2 2 5 5
MAPK: Antibodies, Proteins, Kits, siRNA and Reagents
07-568
Anti-phospho-c-Jun (Thr91/Thr93) H M WB APur Sh IgG 100 µL 07-570
Protein
c-Jun (1-169)-GST, soluble KA 100 µg 14-195
siRNA
c-Jun siRNA/siAb Assay Kit H WB RNAi 1 kit 60-084
c-Jun
List of Antibodies
275 Fibronectin F3648 P y n/d n/d
276 Fibronectin F7387 M y y n/d
277 Filamin F1888 M n/d n/d n/d
278 Filensin F1043 M y y n/d
279 FKHR (FOXO1a) F6928 M y n/d n/d
280 FKHRL1 (FOXO3a) F2178 P y y
Cytoskeletal Signaling Antibodies, Reagents and Kits
145
Mg2+ Lysis/Wash Buffer, 5X GPA 18 mL 20-168
Protein Phosphatase Dilution Buffer PA 1 mL 20-169
100X GTPgS, 10mM GPA 50 µL 20-176
100X GDP, 100mM GPA 50 µL 20-177
pNPP Ser/Thr Assay Buffer
Page 1 of 2